Literature DB >> 19049736

Eight-year outcomes of tricuspid annuloplasty using autologous pericardial strip for functional tricuspid regurgitation.

Byung-Chul Chang1, Suk-Won Song, Sak Lee, Kyung-Jong Yoo, Meyun-Shick Kang, Namsik Chung.   

Abstract

BACKGROUND: Although several techniques of tricuspid annuloplasty have been used to treat tricuspid regurgitation (TR), TR can persist or recur with redilatation of the annulus or disease progression. We compared the long-term results of newly developed tricuspid annuloplasty procedure using autologous pericardial strip with that of conventional suture annuloplasty.
METHODS: From January 1997 to April 2006, 334 patients (mean age, 52.7 years) underwent tricuspid annuloplasty for functional TR. Concomitant procedures included mitral valve replacement in 261 patients and mitral-aortic valve replacement in 73. We performed conventional suture annuloplasty (De Vega or Kay) in 117 patients and autologous pericardial strip annuloplasty in 217 patients.
RESULTS: There were 8 in-hospital deaths (mortality, 2.4%). Mean follow-up was 42.1 months, and total follow-up duration was 1,145 patient-years. Significant TR before discharge was noted in 34 patients (11.1%). The severity of TR improved with time in the autologous pericardial strip annuloplasty group; however, it became worse in conventional suture annuloplasty group (p = 0.05). Multivariate analysis demonstrated that preoperative severity of TR and conventional suture annuloplasty were significant predictors of recurrent TR. Overall survival was comparable between two groups (p = 0.742); however, recurrence-free survival was better for the autologous pericardial strip annuloplasty group than for the conventional suture annuloplasty group (86.8% versus 71.9%; p = 0.039).
CONCLUSIONS: The long-term recurrence-free survival after autologous pericardial strip annuloplasty appeared to be better than that of conventional suture annuloplasty. Autologous pericardial strip annuloplasty appears to be a simple, easily reproducible, and valid option for surgical treatment of functional TR.

Entities:  

Mesh:

Year:  2008        PMID: 19049736     DOI: 10.1016/j.athoracsur.2008.07.007

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Is a tricuspid annuloplasty ring significantly better than a De Vega's annuloplasty stitch when repairing severe tricuspid regurgitation?

Authors:  Maziar Khorsandi; Amit Banerjee; Harpreet Singh; Aseem R Srivastava
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-28

2.  Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation.

Authors:  Andrea L Axtell; Vijeta Bhambhani; Philicia Moonsamy; Emma W Healy; Michael H Picard; Thoralf M Sundt; Jason H Wasfy
Journal:  J Am Coll Cardiol       Date:  2019-05-06       Impact factor: 24.094

3.  Evolving indications for tricuspid valve surgery.

Authors:  Patrick M McCarthy; Virna L Sales
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-12

4.  Surgical treatment of tricuspid regurgitation after mitral valve surgery: a retrospective study in China.

Authors:  Zong-Xiao Li; Zhi-Peng Guo; Xiao-Cheng Liu; Xiang-Rong Kong; Wen-Bin Jing; Tie-Nan Chen; Wan-Li Lu; Guo-Wei He
Journal:  J Cardiothorac Surg       Date:  2012-04-10       Impact factor: 1.637

5.  De Vega annuloplasty for functional tricupsid regurgitation: concept of tricuspid valve orifice index to optimize tricuspid valve annular reduction.

Authors:  Ho Young Hwang; Hyoung Woo Chang; Dong Seop Jeong; Hyuk Ahn
Journal:  J Korean Med Sci       Date:  2013-11-26       Impact factor: 2.153

6.  Impact of severe tricuspid regurgitation on long term survival.

Authors:  Anita Sadeghpour; Mehri Hassanzadeh; Majid Kyavar; Hooman Bakhshandeh; Nasim Naderi; Behshid Ghadrdoost; Arezou Haghighat Talab
Journal:  Res Cardiovasc Med       Date:  2013-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.